Cell therapy weekly: FDA files for permanent injunctions against two for-profit stem cell clinics
This week: FDA acts on for-profit stem cell clinics, gene therapy price tags predicted to top US$1 million and an industry-academic partnership seeks to develop an off-the-shelf CAR-T therapy.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.